A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
Latest Information Update: 28 Nov 2022
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate mofetil; Prednisone; Tacrolimus; Tacrolimus
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 22 Nov 2022 Status changed from active, no longer recruiting to completed.
- 22 Aug 2022 Planned End Date changed from 30 May 2022 to 30 Sep 2022.
- 14 Mar 2022 Results published in the American Journal of Transplantation